• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

HIV researcher will head NIH ’s infectious disease institute
The infectious disease institute at the U.S. National Institutes of Health (NIH) will soon have its first new chief in nearly 4 decades. Jeanne Marrazzo, an expert on sexually transmitted infections, will become director of the National Institute of Allergy and Infectious Diseases (NIAID) in the fall. She will succeed Anthony Fauci, who stepped down in December 2022 after 38 years at NIAID’s helm. Marrazzo, 61, currently directs the Division of Infectious Diseases at the University of Alabama at Birmingham (UAB). A physician and epidemiologist, she has expertise in HIV prevention, vaginal infections, horm...
Source: ScienceNOW - August 2, 2023 Category: Science Source Type: news

University of Alabama HIV researcher will head NIH ’s infectious disease institute
The infectious disease institute at the U.S. National Institutes of Health (NIH) will soon have its first new chief in nearly 4 decades. Jeanne Marrazzo, an expert on sexually transmitted infections, will become director of the National Institute of Allergy and Infectious Diseases (NIAID) in the fall. She will succeed Anthony Fauci, who stepped down in December 2022 after 38 years at NIAID’s helm. Marrazzo, 61, currently directs the Division of Infectious Diseases at the University of Alabama at Birmingham (UAB). A physician and epidemiologist, she has expertise in HIV prevention, vaginal infections, horm...
Source: ScienceNOW - August 2, 2023 Category: Science Source Type: news

What You Need to Know About Pfizer ' s COVID-19 Vaccine, According to an Immunobiologist
What You Need to Know About Pfizer's COVID-19 Vaccine, According to an Immunobiologist University of Arizona immunobiologist Deepta Bhattacharya says the COVID-19 vaccine is safe, and he will take it when it becomes available. Mikayla Mace Today University Communications201208_TMC Mock Vaccine.jpg Cars line up during a COVID-19 vaccination distribution run-through at Tucson Medical Center. Pima CountyHealthCOVID-19 Media contact(s)Mikayla Mace Science Writer, University Communicationsmikaylamace@arizona.edu520-621-1878 Researcher contact(s)Deepta Bhattacharya Department of Immunobiologydeeptab@email.arizona....
Source: The University of Arizona: Health - December 15, 2020 Category: Universities & Medical Training Authors: mikaylamace Source Type: research

What You Need to Know About Pfizer ' s COVID-19 Vaccine
What You Need to Know About Pfizer's COVID-19 Vaccine University of Arizona immunobiologist Deepta Bhattacharya says the COVID-19 vaccine is safe, and he will take it when it becomes available. Mikayla Mace Tuesday University Communications201208_TMC Mock Vaccine.jpg Cars line up during a COVID-19 vaccination distribution run-through at Tucson Medical Center. Pima CountyHealthCOVID-19 Media contact(s)Mikayla Mace Science Writer, University Communicationsmikaylamace@arizona.edu520-621-1878 Researcher contact(s)Deepta Bhattacharya Department of Immunobiologydeeptab@email.arizona.edu520-626-8088Americans began ...
Source: The University of Arizona: Health - December 15, 2020 Category: Universities & Medical Training Authors: mikaylamace Source Type: research

How Convalescent Plasma Could Help Fight COVID-19
The last time most of us gave any thought to antibodies was probably in high school biology, but we’re getting a crash refresher course thanks to COVID-19. They are, after all, the key to our best defenses against SARS-CoV-2, the virus that’s caused the global pandemic. People who have been infected likely rely on antibodies to recover, and antibodies are what vaccines are designed to produce. Or at least that’s what infectious-disease and public-health experts assume for now. Because SARS-CoV-2 is such a new virus, even the world’s best authorities aren’t yet sure what it will take to build p...
Source: TIME: Health - August 24, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Next-Generation Approaches for the Treatment of Food Allergy
AbstractPurpose of ReviewIgE-mediated food allergies are an increasing health concern, and current management includes food avoidance and use of emergency medications. Effective treatment of food allergy is highly desirable. Next generation approaches for the treatment of food allergy aim to improve both safety and efficacy, potentially including long-term tolerance.Recent FindingsOral immunotherapy (OIT) and epicutaneous immunotherapy (EPIT) will likely be integrated into clinical practice as part of food allergy management in the near future. Newer approaches, such as sublingual immunotherapy (SLIT), modified proteins, l...
Source: Current Allergy and Asthma Reports - January 28, 2019 Category: Allergy & Immunology Source Type: research